pubmed-article:15374529 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0012314 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0024535 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0039667 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0205468 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:15374529 | lifeskim:mentions | umls-concept:C0700599 | lld:lifeskim |
pubmed-article:15374529 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15374529 | pubmed:dateCreated | 2004-9-17 | lld:pubmed |
pubmed-article:15374529 | pubmed:abstractText | The point mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) and the dihydropteroate synthase (dhps) genes that are linked to sulphadoxine-pyrimethamine (SP) resistance in vitro have been well characterised. To determine whether a few of these mutations could predict SP treatment failure in vivo, two mutations (Asn-108 and Arg-59) in the dhfr gene and one (Glu-540) in the dhps gene were analysed according to the risk of SP parasitological failure (RI-RIII) at day 28 in pre-treatment isolates in 79 Ugandan children aged 6-59 (mean = 18.4, S.D. = 8.8) months with uncomplicated falciparum malaria. Neither the dhfr-108 (P = 0.3) nor the dhps-540 (P = 0.6) or dhfr-108 + dhps-540 (P = 0.04) mutations were significantly associated with SP parasitological failure. However, the dhfr-108 + dhfr-59 (P = 0.04), the dhfr-59 + dhps-540 (P = 0.04) and the dhfr-108 + dhfr-59 + dhps-540 (P = 0.02) mutations significantly increased the risk for SP parasitological failure. Our findings confirm an earlier report that the dhfr-59 and the dhps-540 mutations could be useful genetic markers for rapid screening of populations at high risk of SP resistance. | lld:pubmed |
pubmed-article:15374529 | pubmed:language | eng | lld:pubmed |
pubmed-article:15374529 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15374529 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15374529 | pubmed:month | Dec | lld:pubmed |
pubmed-article:15374529 | pubmed:issn | 1567-1348 | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:EgwangThomas... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:MutabingwaThe... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:TalisunaAmbro... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:LangiPeterP | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:D'AlessandroU... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:WatkinsWillia... | lld:pubmed |
pubmed-article:15374529 | pubmed:author | pubmed-author:Nalunkuma-Kaz... | lld:pubmed |
pubmed-article:15374529 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15374529 | pubmed:volume | 4 | lld:pubmed |
pubmed-article:15374529 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15374529 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15374529 | pubmed:pagination | 321-7 | lld:pubmed |
pubmed-article:15374529 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:meshHeading | pubmed-meshheading:15374529... | lld:pubmed |
pubmed-article:15374529 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15374529 | pubmed:articleTitle | Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. | lld:pubmed |
pubmed-article:15374529 | pubmed:affiliation | Ministry of Health, Epidemiological Surveillance Division, P. O. Box 7272, Kampala, Uganda, Belgium. atalisuna@yahoo.com | lld:pubmed |
pubmed-article:15374529 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15374529 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15374529 | lld:pubmed |